• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青春期发育及其决定因素在依赖输血的地中海贫血青少年中。

Pubertal Development and its Determinants in Adolescents With Transfusion-Dependent Thalassemia.

机构信息

Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi.

Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi. Correspondence to: Dr Anju Seth, Director Professor, Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi 110 001, India.

出版信息

Indian Pediatr. 2021 Jul 15;58(7):635-638. Epub 2021 Mar 26.

PMID:33772533
Abstract

OBJECTIVES

To assess pubertal development and its determinants in adolescents with transfusion-dependent thalassemia (TDT).

METHODS

In this cross-sectional study from a tertiary teaching hospital in Delhi, records of adolescents aged 17-19 years with TDT on regular transfusion at thalassemia day-care centre were reviewed. Pubertal development and its determinants were assessed.

RESULTS

Records of 58 (33 male) adolescents with TDT were reviewed. Among them, 42 (72.4%) had normal/delayed onset with spontaneous progression of puberty, while 16 (27.6%) had pubertal arrest/failure and received hormonal replacement therapy (HRT). Short stature was observed in all adolescents on HRT. Amongst other endocrinopathies, only hypoparathyroidism was found to be significantly higher in the HRT group. On multivariate analysis, serum ferritin (OR-1.005, 95% CI 1.002, 1.009) was observed to be the only significant determinant of pubertal arrest/failure.

CONCLUSIONS

A significant proportion of adolescents with TDT continue to have pubertal arrest/failure. High systemic iron load is the key determinant for this.

摘要

目的

评估依赖输血的地中海贫血(TDT)青少年的青春期发育及其决定因素。

方法

本研究为德里一家三级教学医院的横断面研究,对地中海贫血日间护理中心接受定期输血的 17-19 岁 TDT 青少年的记录进行了回顾。评估了青春期发育及其决定因素。

结果

共回顾了 58 名(33 名男性)TDT 青少年的记录。其中,42 名(72.4%)有正常/延迟开始的青春期,自发进展,而 16 名(27.6%)有青春期停滞/失败,并接受了激素替代治疗(HRT)。所有接受 HRT 的青少年都存在身材矮小。在其他内分泌疾病中,仅发现甲状旁腺功能减退症在 HRT 组中的发生率明显更高。多变量分析显示,血清铁蛋白(OR-1.005,95%CI 1.002,1.009)是青春期停滞/失败的唯一显著决定因素。

结论

相当一部分 TDT 青少年仍存在青春期停滞/失败。高全身铁负荷是其主要决定因素。

相似文献

1
Pubertal Development and its Determinants in Adolescents With Transfusion-Dependent Thalassemia.青春期发育及其决定因素在依赖输血的地中海贫血青少年中。
Indian Pediatr. 2021 Jul 15;58(7):635-638. Epub 2021 Mar 26.
2
Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.马来西亚砂拉越依赖输血的地中海贫血患者的铁负荷和内分泌并发症:一项回顾性研究。
Med J Malaysia. 2024 May;79(3):281-287.
3
Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia.马来西亚依赖输血的地中海贫血儿童的生长和内分泌紊乱的患病率。
Singapore Med J. 2019 Jun;60(6):303-308. doi: 10.11622/smedj.2018155. Epub 2018 Dec 17.
4
Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.接受口服铁螯合治疗的重型地中海贫血青少年的内分泌病
Paediatr Int Child Health. 2016 Feb;36(1):22-7. doi: 10.1179/2046905514Y.0000000160. Epub 2014 Oct 13.
5
Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.槟城医院依赖输血的地中海贫血症中的内分泌并发症患病率:一项初步研究。
Med J Malaysia. 2020 Jan;75(1):33-37.
6
Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.重型β地中海贫血中生长激素和促性腺激素分泌所致生长及青春期发育障碍的患病率
Arch Iran Med. 2006 Oct;9(4):329-34.
7
Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.重型地中海贫血和镰状细胞病的输血依赖型儿童及青少年的生长与青春期发育:一项对比研究。
J Trop Pediatr. 1999 Feb;45(1):23-30. doi: 10.1093/tropej/45.1.23.
8
Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.β 重型地中海贫血症患者经医学治疗后的血清铁蛋白水平与内分泌异常。
Ann Hematol. 2012 Jul;91(7):1107-14. doi: 10.1007/s00277-012-1412-7. Epub 2012 Jan 28.
9
The experience of a tertiary unit on the clinical phenotype and management of hypogonadism in female adolescents and young adults with transfusion dependent thalassemia.一家三级医疗单位对依赖输血的地中海贫血女性青少年和年轻成人性腺功能减退的临床表型及管理的经验。
Acta Biomed. 2019 Jan 23;90(1):158-167. doi: 10.23750/abm.v90i1.8143.
10
The effect of zinc deficiency and iron overload on endocrine and exocrine pancreatic function in children with transfusion-dependent thalassemia: a cross-sectional study.锌缺乏和铁过载对输血依赖型地中海贫血儿童内分泌和外分泌胰腺功能的影响:一项横断面研究。
BMC Pediatr. 2021 Oct 22;21(1):468. doi: 10.1186/s12887-021-02940-5.

引用本文的文献

1
Gene therapy in transfusion-dependent non-β0/β0 genotype β-thalassemia: first real-world experience of beti-cel.输血依赖型非β0/β0基因型β地中海贫血的基因治疗:beti-cel的首次真实世界经验。
Blood Adv. 2025 Jan 14;9(1):29-38. doi: 10.1182/bloodadvances.2024014104.
2
Endocrinopathies in beta thalassemia: a narrative review.β地中海贫血中的内分泌病:一项叙述性综述。
Hormones (Athens). 2024 Jun;23(2):205-216. doi: 10.1007/s42000-023-00515-w. Epub 2023 Dec 16.
3
Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?血红蛋白病中的内分泌病:铁的作用是什么?
Int J Mol Sci. 2023 Nov 13;24(22):16263. doi: 10.3390/ijms242216263.
4
[Endocrine disorders in patients with transfusion-dependent hereditary anemias].[输血依赖型遗传性贫血患者的内分泌紊乱]
Probl Endokrinol (Mosk). 2022 Jul 27;68(6):121-130. doi: 10.14341/probl13149.
5
New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.新实体——地中海贫血内分泌疾病:重型β地中海贫血与内分泌受累
Diagnostics (Basel). 2022 Aug 9;12(8):1921. doi: 10.3390/diagnostics12081921.